The Clinical Experience of 22 Years Analysis of Therapeutic and Surgical Treatment of the Early Glaucoma
https://doi.org/10.18008/1816-5095-2022-4-906-916
Abstract
The article presents the clinical case of a 22-year follow-up of a patient with early glaucoma whose visual functions were stabilized during the first 12 years after trabeculectomy and during the next 10 years of therapeutic treatment due to poor compliance the disease progressed to advanced glaucoma. As a result, in 2021 there were pronounced changes in the visual field of the left eye, the main cause, probably, was a vascular accident against the background of low perfusion pressure and uncompensated IOP. After a thorough analysis and scrupulous selection of eyedrops, IOP was compensated with laser and instillation of Dortimol Antiglau, which showed the best results of tolerability and achievement of tolerant pressure. This article presents data from clinical and instrumental studies and analyzes factors reflecting the importance of assessing the level of compliance in reducing the glaucoma progression.
About the Authors
N. V. Мakashova
M.M. Krasnov Scientific Research Institute of Eye Diseases
Russian Federation
Russian Federation
MD, senior research officer
Rossolimo str., 11A, B, Moscow, 119021, Russian Federation
A. E. Vasilyeva
Medical Center “Capital”
Russian Federation
Russian Federation
PhD, head of the Department of ophthalmology
Leninsky ave., 90, Moscow, 119021, Russian Federation
References
1. Malihi M., Moura Filho E.R., Hodge D.O., et al. Long term trends in glaucoma related blindness in Olmsted County, Minnesota. Ophthalmology. 2014;121:134–141. DOI: 10.1016/j.ophtha.2013.09.003
2. Peters D., Bengtsson B., Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol. 2013;156:724–730. DOI: 10.1016/j.ajo.2013.05.027
3. Lu V.H., Goldberg I., Lu C.Y. Use of glaucoma medications: state of the science and directions for observational research. Am J Ophthalmol. 2010;150:569–574. DOI: 10.1016/j.ajo.2010.05.005
4. Olthoff C.M., Schouten J.S., van de Borne B.W., Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence based review. Ophthalmology. 2005 Jun;112(6):953–961. DOI: 10.1016/j.ophtha.2004.12.035. PMID: 15885795
5. European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th EditionBritish. Journal of Ophthalmology. 2021;105:1–169. DOI: 10.1136/bjophthalmol-2021-egsguidelines
6. Musch D.C., Gillespie B.W., Lichter P.R., Niziol L.M., Janz N.K.; CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009 Feb;116(2):200–207. DOI: 10.1016/j.ophtha.2008.08.051. Epub 2008 Nov 18. PMID: 19019444; PMCID: PMC3316491
7. Pisella P.J., Pouliquen P., Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002 Apr;86(4):418–423. DOI: 10.1136/bjo.86.4.418
8. Jaenen N., Baudouin C., Pouliquen P., Manni G., Figueiredo A., Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007 May Jun;17(3):341–349. DOI: 10.1177/112067210701700311
9. Kim, K.E., Oh, S., Baek, S.U., et al. Ocular Perfusion Pressure and the Risk of Open-Angle Glaucoma: Systematic Review and Meta-analysis. Sci Rep. 2020;10:10056. DOI: 10.1038/s41598-020-66914-w
Review
For citations:
Мakashova N.V., Vasilyeva A.E. The Clinical Experience of 22 Years Analysis of Therapeutic and Surgical Treatment of the Early Glaucoma. Ophthalmology in Russia. 2022;19(4):906-916. (In Russ.) https://doi.org/10.18008/1816-5095-2022-4-906-916
Views:
361
Email this article 